A phase II study of bevacizumab plus erl
โ
Andrew H. Ko; Alan P. Venook; Emily K. Bergsland; R. Kate Kelley; W. Michael Kor
๐
Article
๐
2010
๐
Springer
๐
English
โ 266 KB